ALLMedicine™ Nail Disorders Center
Research & Reviews 102 results
https://www.mdedge.com/dermatology/article/261287/hair-nails/treatment-several-nail-disorders-reviewed
Thomas R. Collins
Feb 17th, 2023 - ORLANDO – From differentiating them from mimics to choosing the best treatment course, Molly Hinshaw, MD, reviewed some of the ins and outs of managing nail disorders at the ODAC Dermatology, Aesthetic, & Surgical Conference. Dr.
https://doi.org/10.1111/jocd.15660
Journal of Cosmetic Dermatology; Nasif GA, Amin AA et. al.
Jan 31st, 2023 - Onychomycosis (OM) represents about 50% of nail disorders. Oral antifungals have proven efficacy in the treatment of onychomycosis but their associated side effects limit their use. Accordingly, there is an increased need for a safe and effective ...
https://clinicaltrials.gov/ct2/show/NCT05699499
Jan 26th, 2023 - Retronychia is the growth of the proximal nail plate into the proximal nail fold which was first described in 1999 by De Berker and Rendall. The disorder is common and most frequently affects women (~82%); the estimated average age is 39 years. Th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874876
International Journal of Dermatology; Kutlu Ö, Demircan YT et. al.
Oct 26th, 2022 - A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. This is a multicenter study conduc...
https://doi.org/10.12788/cutis.0592
Cutis Nanda S
Oct 1st, 2022 - Nail cosmetics are an integral practice in many patients' lives. However, the manicuring process can result in nail damage via instrumentation, allergens in nail polish, and infections. Many of these nail disorders are preventable through proper e...
Drugs 9 results see all →
Clinicaltrials.gov 6 results
https://clinicaltrials.gov/ct2/show/NCT05699499
Jan 26th, 2023 - Retronychia is the growth of the proximal nail plate into the proximal nail fold which was first described in 1999 by De Berker and Rendall. The disorder is common and most frequently affects women (~82%); the estimated average age is 39 years. Th...
https://clinicaltrials.gov/ct2/show/NCT03656341
Oct 25th, 2019 - One in three older adults have foot problems such as bunions, corns, calluses, foot pain, or nail disorders, but those problems are often ignored or overlooked until they threaten mobility or quality of life. With proper self-management, skin and ...
https://clinicaltrials.gov/ct2/show/NCT04092413
Sep 17th, 2019 - Nails are characteristically affected in skin diseases such as psoriasis (speckling, psoriatic oil spot, crumbling nails, pachyonychia) ,lichen( anonychia, dystrophy) ,alopecia areata (speckling, trachyonychia, longitudinal grooves, leukonychia), ...
https://clinicaltrials.gov/ct2/show/NCT02979184
Apr 18th, 2018 - Lymphedema is the result of an intra-tissue fluid accumulation by failure of the lymphatic system to absorb the excess fluid from the veinulo-capillary circulation. Lymphedema can be primitive with aplasia or hypoplasia of the lymphatic vessels or...
https://clinicaltrials.gov/ct2/show/NCT00356915
Feb 9th, 2017 - Onychomycosis is common and accounts for about half of all nail disorders. Usually the cause is due to dermatophytes, either Trichophyton rubrum (71%) or Trichophyton mentagrophytes (20%) but may also be due to yeast infection, usually Candida alb...
News 35 results
https://www.mdedge.com/dermatology/article/261287/hair-nails/treatment-several-nail-disorders-reviewed
Thomas R. Collins
Feb 17th, 2023 - ORLANDO – From differentiating them from mimics to choosing the best treatment course, Molly Hinshaw, MD, reviewed some of the ins and outs of managing nail disorders at the ODAC Dermatology, Aesthetic, & Surgical Conference. Dr.
https://www.onclive.com/view/talquetamab-plus-daratumumab-generates-high-response-rate-in-cd38-refractory-myeloma
Sep 29th, 2022 - The combination of talquetamab and daratumumab and hyaluronidase-fihj (Darzalex Faspro) led to early onset and durable responses that deepened over time in patients with heavily pretreated multiple myeloma, most of whom were anti-CD38 refractory, ...
https://www.onclive.com/view/talquetamab-adverse-event-management-in-myeloma-requires-early-oral-dermatologic-interventions
Aug 25th, 2022 - Effective methods of mitigating oral and dermatologic treatment-emergent adverse events (TEAEs) commonly reported with talquetamab may include preventative tactics initiated at the start of therapy. In a presentation during the 19th International ...
https://www.mdedge.com/familymedicine/article/257109/dermatology/spotted-white-fingernails
MDedge Family Medicine;
Aug 18th, 2022 - White nail changes are broadly called leukonychia: “leuko” meaning white and “nychia” referring to the nail. Scattered or single asymptomatic cloudy white nail lesions occurring without other associated skin or nail disorders are more specifically.
https://www.onclive.com/view/talquetamab-continues-to-impress-in-relapsed-refractory-multiple-myeloma
Sep 10th, 2021 - Talquetamab, an off-the-shelf T-cell redirecting, GP3C5D-targeting agent, has continued to show promising clinical activity in patients with relapsed/refractory multiple myeloma, especially when given at the recommended phase 2 dose (RP2D) of 405 ...